date:Nov 30, 2018
challenge. The goal is to get the participants to ingest a dose of 600 mg or more without dose-limiting symptoms.
Of the 551 participants, 496 were ages 4 to 17. Of these, 250, or 67.2% of the participants who received the active treatment, were able to eat a dose of 600 mg of more of peanut protein during the exit food challenge. Just 4% of the children who were given the placebo could eat the same amount of peanut without reacting.
Adverse events did affect more than 95% of the younger parti